HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kitagawa, Y. Articles by Yonekura, Y. Search for Related Content PubMed PubMed Citation Articles by Kitagawa, Y. Articles by Yonekura, Y.

Prospective Comparison of ¹⁸F-FDG PET with Conventional Imaging Modalities (MRI, CT, and ⁶⁷Ga Scintigraphy) in Assessment of Combined Intraarterial Chemotherapy and Radiotherapy for Head and Neck Carcinoma

¹ Department of Dentistry and Oral Surgery, Fukui Medical University, Fukui, Japan
² Biomedical Imaging Research Center, Fukui Medical University, Fukui, Japan
³ Department of Radiology, Fukui Medical University, Fukui, Japan

To preserve the oral organs and functions in patients with head and neck carcinoma, accurate determination of the appropriate treatment after neoadjuvant chemotherapy and radiotherapy is of critical importance. We evaluated the diagnostic accuracy of ¹⁸F-FDG PET relative to that of other conventional imaging modalities in the assessment of therapeutic response after combined intraarterial chemotherapy and radiotherapy as an organ preservation protocol. Methods: The study was prospectively performed on 23 consecutive patients with head and neck squamous cell carcinoma who completed the treatment regimen and underwent 2 ¹⁸F-FDG PET studies before and after neoadjuvant chemoradiotherapy. ⁶⁷Ga scintigraphy (only before therapy) as well as MRI and CT (both before and after therapy) were also performed. All images were blindly and independently interpreted without knowledge of histologic findings. The level of confidence in image interpretation was graded by means of a 5-point rating system (0 = definitely no tumor to 4 = definite tumor). Results: Before treatment, ¹⁸F-FDG PET detected primary tumors in all 23 patients and was more sensitive (100%) than MRI (18/23; 78.3%), CT (15/22; 68.2%), and ⁶⁷Ga scintigraphy (8/20; 40%), with a confidence level of 3 or 4 as a positive tumor finding. After chemoradiotherapy, residual tumors were histologically confirmed in 4 patients (pathologic complete response rate, 19/23; 82.6%). Although posttreatment ¹⁸F-FDG PET showed almost equal sensitivity (4/4; 100%) compared with MRI (3/3; 100%) or CT (3/4; 75%), its specificity (17/19; 89.5%) was superior to MRI (7/17, 41.2%) and to CT (10/17; 58.8%) for primary lesions. Regarding metastases to neck lymph nodes, only specificity for posttreatment images was calculated because no metastasis was confirmed in any patients after treatment. Six subjects had ¹⁸F-FDG PET-positive lymph nodes, which had pathologically no tumor cells and suggested an inflammatory reactive change after therapy. Therefore, the specificity of posttreatment ¹⁸F-FDG PET (17/23; 73.9%) was almost identical to that of MRI (17/20; 85%) and CT (16/21; 76.2%) for neck metastasis. With combined chemoradiotherapy monitored with ¹⁸F-FDG PET, 8 patients avoided surgery and the remaining 15 patients underwent a reduced form of surgery. Conclusion: ¹⁸F-FDG PET facilitates differentiation of residual tumors from treatment-related changes after chemoradiotherapy, which may be occasionally difficult to characterize by anatomic images. ¹⁸F-FDG PET has a clinical impact for the management of patients with head and neck cancers after neoadjuvant chemoradiotherapy by optimizing surgical treatment for each patient and contributes to the improvement of the patient’s quality of life.

Key Words: PET • head and neck cancer • chemotherapy • radiotherapy • organ preservation

This article has been cited by other articles:

				A. Quon, N. J. Fischbein, I. R. McDougall, Q.-T. Le, B. W. Loo Jr., H. Pinto, and M. J. Kaplan Clinical Role of 18F-FDG PET/CT in the Management of Squamous Cell Carcinoma of the Head and Neck and Thyroid Carcinoma J. Nucl. Med., January 1, 2007; 48(1_suppl): 58S - 67S. [Abstract] [Full Text] [PDF]

				J. D. Berry and G. J. R. Cook Positron emission tomography in oncology Br. Med. Bull., December 14, 2006; (2006) ldl013v1. [Abstract] [Full Text] [PDF]

				G. K. von Schulthess, H. C. Steinert, and T. F. Hany Integrated PET/CT: Current Applications and Future Directions Radiology, February 1, 2006; 238(2): 405 - 422. [Abstract] [Full Text] [PDF]

				S. Joshi, M. Wang, J. J. Etu, and J. Pile-Spellman Reducing Cerebral Blood Flow Increases the Duration of Electroencephalographic Silence by Intracarotid Thiopental Anesth. Analg., September 1, 2005; 101(3): 851 - 858. [Abstract] [Full Text] [PDF]